首页> 外文OA文献 >ANALYSIS OF PULMONARY-RELATED CLINICAL MANIFESTATIONS AND HEALTH RESOURCE UTILIZATION IN PATIENTS WITH SEVERE AND NON-SEVERE ALPHA-1 ANTITRYPSIN DEFICIENCY IN THE UNITED STATES

【2h】

ANALYSIS OF PULMONARY-RELATED CLINICAL MANIFESTATIONS AND HEALTH RESOURCE UTILIZATION IN PATIENTS WITH SEVERE AND NON-SEVERE ALPHA-1 ANTITRYPSIN DEFICIENCY IN THE UNITED STATES

机译：肺癌相关临床表现与健康资源利用分析美国严重和非严重α-1抗胰蛋白酶缺乏症的患者

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Ernesto Mayen Herrera; Corey Joseph; Emily Brouwer;
展开▼
作者单位

展开▼
年度 2019
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Alpha-1 Antitrypsin Augmentation Therapy Improves Survival in Severely Deficient Patients with Predicted FEV1 Between 10% and 60%: A Retrospective Analysis of the NHLBI Alpha-1 Antitrypsin Deficiency Registry [J] . Franck F Rahaghi, Richard Monk, Viswanathan Ramakrishnan, International Journal of Chronic Obstructive Pulmonary Disease . 2020,第1期

机译：Alpha-1 Anturigrypsin增强治疗在预测FEV1的严重缺陷患者中提高了存活率10％至60％：NHLBIα-1抗抗核蛋白缺乏登记处的回顾性分析
2. Clinical utility of alpha-1 proteinase inhibitor in the management of adult patients with severe alpha-1 antitrypsin deficiency: a review of the current literature [J] . David G Parr, Beatriz Lara Drug Design, Development and Therapy . 2017,第5期

机译：α-1蛋白酶抑制剂在成人严重α-1抗胰蛋白酶缺乏症患者治疗中的临床应用：当前文献综述
3. Low Yield and Utilization of Confirmatory Testing in a Cohort of Patients with Liver Disease Assessed for Alpha-1 Antitrypsin Deficiency [J] . Tapper Elliot B., Patwardhan Vilas R., Curry Michael Digestive Diseases and Sciences . 2015,第6期

机译：评估患有α-1抗胰蛋白酶缺乏症的肝病患者队列的低产率和验证性测试的利用
4. Duration of Subclinical Mastitis Prior to Occurrence of Non-severe Clinical Mastitis — Results of a Preliminary Analysis [C] . Annual Meeting of The National Mastitis Council . 2020

机译：在发生非严重临床乳腺炎之前亚临床乳腺炎的持续时间 - 初步分析的结果
5. Clinical practice guideline implementation for alpha-1 antitrypsin deficiency testing: Evaluation of an innovative method. [D] . Steffen, Priscilla Torres. 2010

机译：alpha-1抗胰蛋白酶缺乏症检测的临床实践准则实施：一种创新方法的评估。
6. Alpha-1 Antitrypsin Augmentation Therapy Improves Survival in Severely Deficient Patients with Predicted FEV1 Between 10 and 60: A Retrospective Analysis of the NHLBI Alpha-1 Antitrypsin Deficiency Registry [O] . Franck F Rahaghi, Richard Monk, Viswanathan Ramakrishnan, 2020

机译：Alpha-1 Anturigrypsin增强治疗在预测FEV1的严重缺陷患者中提高了存活率10％至60％：NHLBIα-1抗抗核蛋白缺乏登记处的回顾性分析
7. PRS18 ANALYSIS OF PULMONARY-RELATED CLINICAL MANIFESTATIONS AND HEALTHCARE RESOURCE USE IN PATIENTS IN THE UNITED STATES WITH ALPHA-1 ANTITRYPSIN DEFICIENCY [O] . E. Mayen Herrera, C. Joseph, M. Czorniak 2020

机译：PRS18分析肺部相关临床表现和医疗资源在美国患者患者用α-1抗胰蛋白酶缺乏分析

ANALYSIS OF PULMONARY-RELATED CLINICAL MANIFESTATIONS AND HEALTH RESOURCE UTILIZATION IN PATIENTS WITH SEVERE AND NON-SEVERE ALPHA-1 ANTITRYPSIN DEFICIENCY IN THE UNITED STATES

著录项

引文网络

相似文献

相关主题

期刊订阅